Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness analysis of bundled innovative devices versus standard approach in the prevention of unscheduled peripheral venous catheters removal due to complications in France.
Maunoury F, Drugeon B, Boisson M, Marjanovic N, Couvreur R, Mimoz O, Guenezan J; CLEAN-3 Study. Maunoury F, et al. Among authors: drugeon b. PLoS One. 2022 Jun 14;17(6):e0269750. doi: 10.1371/journal.pone.0269750. eCollection 2022. PLoS One. 2022. PMID: 35700207 Free PMC article. Clinical Trial.
Treatment of central line-associated bloodstream infections.
Guenezan J, Drugeon B, Marjanovic N, Mimoz O. Guenezan J, et al. Among authors: drugeon b. Crit Care. 2018 Nov 16;22(1):303. doi: 10.1186/s13054-018-2249-9. Crit Care. 2018. PMID: 30445990 Free PMC article. No abstract available.
Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, combined or not with use of a bundle of new devices, for prevention of short-term peripheral venous catheter-related infectious complications and catheter failure: an open-label, single-centre, randomised, four-parallel group, two-by-two factorial trial: CLEAN 3 protocol study.
Guenezan J, Drugeon B, O'Neill R, Caillaud D, Sénamaud C, Pouzet C, Seguin S, Frasca D, Mimoz O. Guenezan J, et al. Among authors: drugeon b. BMJ Open. 2019 Apr 2;9(4):e028549. doi: 10.1136/bmjopen-2018-028549. BMJ Open. 2019. PMID: 30944142 Free PMC article. Clinical Trial.
Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial.
Guenezan J, Marjanovic N, Drugeon B, Neill RO, Liuu E, Roblot F, Palazzo P, Bironneau V, Prevost F, Paul J, Pichon M, Boisson M, Frasca D, Mimoz O; CLEAN-3 trial investigators. Guenezan J, et al. Among authors: drugeon b. Lancet Infect Dis. 2021 Jul;21(7):1038-1048. doi: 10.1016/S1473-3099(20)30738-6. Epub 2021 Feb 1. Lancet Infect Dis. 2021. PMID: 33539734 Clinical Trial.
Peripheral venous catheter colonization after skin disinfection with 0.5% aqueous sodium hypochlorite, preceded or not by one application of 70% ethanol (DACLEAN): a single-centre, randomized, open-label, pilot study.
Drugeon B, Pichon M, Marjanovic N, Mousse S, Seguin S, Raynaud C, Rahoui A, Frasca D, Mimoz O, Guenezan J. Drugeon B, et al. J Hosp Infect. 2022 Feb;120:123-126. doi: 10.1016/j.jhin.2021.11.012. Epub 2021 Nov 23. J Hosp Infect. 2022. PMID: 34822950 Free article. Clinical Trial.
16 results